P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease
paradigm_report_works_22122023
10.1007_s12325-022-02097-2
5
5
2022
1881
1894
article
39
cc-by-nc
https://link.springer.com/content/pdf/10.1007/s12325-022-02097-2.pdf
Advances in Therapy
Springer Science and Business Media LLC
Robert A. Hauser
Nir Giladi
Werner Poewe
Jonathan M. Brotchie
Hadas Friedman
Sheila Oren
Pninit Litman
False
10.1007/s12325-022-02097-2
P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our
Terms of Service and Privacy Policy.